Jean Champagne - Concepedia

Author

Jean Champagne

Also Known As

Champagne, Jean, J Champagne, J. Champagne, J.S. Champagne, JEAN CHAMPAGNE, Jean Champagne, Paul Novak, Robert Sangrigoli

214

Publications

9.6K

Citations

H-Index

Concepts

All Affiliations

Montreal Heart Institute Université Laval Institut universitaire de cardiologie et de pneumologie de Québec University of British Columbia Southlake Regional Health Center

About

Jean Champagne is an author at Montreal Heart Institute specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	38	3.1K
2	Public Health	17	20	1.3K
3	Engineering	4	4	378
4	Biomedical Engineering	3	3	370
5	Health Sciences	2	2	323

Jean Champagne

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation Douglas L. Packer, Robert Kowal, Kevin R. Wheelan, Journal of the American College of Cardiology ThrombosisPulmonary EmbolismPulmonary CirculationFibrinolysisMedicine	2013	861
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation Jason G. Andrade, George A. Wells, Marc W. Deyell, New England Journal of Medicine	2020	736
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2) Carlos A. Morillo, Atul Verma, Stuart J. Connolly, JAMA	2014	656
Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring Jason G. Andrade, Jean Champagne, Marc Dubuc, Circulation	2019	541
Systematic Assessment of Patients With Unexplained Cardiac Arrest Andrew D. Krahn, Jeff S. Healey, Vijay S. Chauhan, Circulation	2009	334
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy Jason G. Andrade, Marc W. Deyell, Laurent Macle, New England Journal of Medicine	2022	330
Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF) Atul Verma, Jean Champagne, John L. Sapp, JAMA Internal Medicine	2012	302
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, The Lancet ThrombosisDose-finding Phase 2Cardiovascular DiseasePharmacologyCardiovascular Pharmacology	2022	296
Usefulness of Fluorine-18 Positron Emission Tomography/Computed Tomography for Identification of Cardiovascular Implantable Electronic Device Infections J. Sarrazin, François Philippon, Michel Tessier, Journal of the American College of Cardiology Medical ElectronicsEngineeringHealth SciencesMedical ImagingDiagnostic Device	2012	280
Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation Therapy Marina Ureña, Josep Rodés‐Cabau, Xavier Freixa, Journal of the American College of Cardiology Percutaneous Coronary InterventionThrombosisDevice TherapyCardiovascular DiseaseNonvalvular Atrial Fibrillation	2013	272

Page 1